These results confirm receptor-mediated cytosolic drug delivery by pH-responsive RNA nanoparticles and demonstrate potential of the 3WJ–drug complex as a novel strategy for receptor-selective drug delivery to cancer cells with high FRα expression. Here, FOLR1 is linked to cancer.